Preventive Treatment of Migraine

被引:9
|
作者
Shapiro, Robert E. [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Neurol, Univ Hlth Ctr, Burlington, VT 05401 USA
来源
HEADACHE | 2012年 / 52卷
关键词
migraine; prophylactic; preventive; QUALITY STANDARDS SUBCOMMITTEE; AMERICAN HEADACHE SOCIETY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; EPISODIC MIGRAINE; CONTROLLED PHASE; ADULTS REPORT; TOPIRAMATE; ONABOTULINUMTOXINA;
D O I
10.1111/j.1526-4610.2012.02242.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a prevalent and disabling episodic brain state with protean symptoms dominated by headache. When migraine attacks are frequent or severe over a sustained period, use of daily preventive medications are indicated to significantly reduce disability and improve quality of life. Recently issued evidence-based guidelines outline an array of pharmaceutical and complementary treatment choices with data establishing them as effective or probably effective for prevention of episodic or menstrually associated migraine. OnabotulinutoxinA is the only Food and Drug Administration-approved medication for the prevention of chronic migraine.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [31] OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2011, 15 (01) : 4 - 7
  • [32] FINESSE: Fremanezumab for Preventive Treatment in Migraine
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schauerte, I.
    Neeb, L.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 174 - 175
  • [33] OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
    Shih-Pin Chen
    Jong-Ling Fuh
    Shuu-Jiun Wang
    [J]. Current Pain and Headache Reports, 2011, 15 : 4 - 7
  • [34] Unmet Needs in Preventive Treatment of Migraine
    Bentivegna, Enrico
    Onan, Dilara
    Martelletti, Paolo
    [J]. NEUROLOGY AND THERAPY, 2023, 12 (02) : 337 - 342
  • [35] New players in the preventive treatment of migraine
    Mitsikostas, Dimos D.
    Rapoport, Alan M.
    [J]. BMC MEDICINE, 2015, 13
  • [36] Zonisamide in the preventive treatment of refractory migraine
    Pascual-Gomez, Julio
    Gracia-Naya, Manuel
    Leira, Rogelio
    Mateos, Valentin
    Carlos Alvaro-Gonzalez, Luis
    Hernando, Ignacio
    Oterino, Agustin
    Iglesias-Diez, Fernando
    Caminero, Ana
    Carlos Garcia-Monco, Juan
    Forcea, Nerea
    Luis Guerrero-Peral, Angel
    Bueno, Valentin
    Santos-Garcia, Diego
    Perez, Celia
    Blanco, Miguel
    Pego-Reigosa, Robustiano
    Rodriguez, Rosa
    Mederer-Hengstl, Susana
    Pato-Pato, Antonio
    Sanchez-Herrero, Joaquin
    Luis Macineiras-Montero, Jose
    Ortega, Fernando
    Arias, Monica
    Diaz-Gonzalez, Manuel
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 (03) : 129 - 132
  • [37] FINESSE: Fremanezumab for Preventive Treatment in Migraine
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schauerte, I.
    Neeb, L.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 117 - 117
  • [38] Memantine in the preventive treatment of refractory migraine
    Bigal, Marcelo
    Rapoport, Alan
    Sheftell, Fred
    Tepper, Deborah
    Tepper, Stewart
    [J]. HEADACHE, 2008, 48 (09): : 1337 - 1342
  • [39] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Blair, Hannah A.
    [J]. CNS DRUGS, 2023, 37 (03) : 255 - 265
  • [40] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Hannah A. Blair
    [J]. CNS Drugs, 2023, 37 : 255 - 265